morpholinoanthracycline mx2 has been researched along with Leukemia P388 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyamoto, K; Shinkai, H; Takahashi, H; Tokiwa, T; Uchida, T | 1 |
| Kawai, H; Komeshima, N; Nakajima, S; Otake, N; Takeuchi, T; Tsuruo, T; Watanabe, M | 1 |
| Kawai, H; Komeshima, N; Nakajima, S; Odagawa, A; Otake, N; Otsuki, N; Tatsuta, K; Umezawa, H; Urata, T; Yoshimoto, H | 1 |
3 other study(ies) available for morpholinoanthracycline mx2 and Leukemia P388
| Article | Year |
|---|---|
Comparative pharmacokinetics of KRN8602, a new morpholino anthracycline, and adriamycin in tumor-bearing mice.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Brain Chemistry; Carubicin; Cell Survival; Chromatography, High Pressure Liquid; Colonic Neoplasms; Doxorubicin; Female; Intestine, Small; Kidney; Leukemia P388; Liver; Lung; Mice; Myocardium; Neoplasm Transplantation; Spleen; Tissue Distribution; Tumor Cells, Cultured | 1996 |
Role of DNA-binding in the cytotoxicity of an anthracycline, R20X2 and its morpholino analog, MX2.
Topics: Animals; Carubicin; Cells, Cultured; Daunorubicin; DNA, Neoplasm; Leukemia P388; Leukemia, Experimental; Rats; Structure-Activity Relationship | 1989 |
New morpholino anthracyclines, MX, MX2, and MY5.
Topics: Animals; Anthracyclines; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Carubicin; Leukemia P388; Mice; Naphthacenes | 1987 |